title: Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective.
abstract: Most cutaneous wounds heal with scar formation. Ideally, an inconspicuous normotrophic scar is formed, but an abnormal scar (hypertrophic scar or keloid) can also develop. A major challenge to scientists and physicians is to prevent adverse scar formation after severe trauma (e.g. burn injury) and understand why some individuals will form adverse scars even after relatively minor injury. Currently, many different models exist to study scar formation, ranging from simple monolayer cell culture to 3D tissue-engineered models even to humanized mouse models. Currently, these high-/medium-throughput test models avoid the main questions referring to why an adverse scar forms instead of a normotrophic scar and what causes a hypertrophic scar to form rather than a keloid scar and also, how is the genetic predisposition of the individual and the immune system involved. This information is essential if we are to identify new drug targets and develop optimal strategies in the future to prevent adverse scar formation. This viewpoint review summarizes the progress on in vitro and animal scar models, stresses the limitations in the current models and identifies the future challenges if scar-free healing is to be achieved in the future.
authors.affiliation: Department of Dermatology, VU University Medical Center, Amsterdam, The Netherlands; Research Institute MOVE, Amsterdam, The Netherlands.
authors.forename: Lenie J
authors.initials: LJ
authors.lastname: van den Broek
authors.forename: Grace C
authors.initials: GC
authors.lastname: Limandjaja
authors.forename: Frank B
authors.initials: FB
authors.lastname: Niessen
authors.forename: Susan
authors.initials: S
authors.lastname: Gibbs
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D017439:Cicatrix, Hypertrophic / Q000473:pathology / Q000503:physiopathology* / Q000517:prevention & control; D006801:Humans; D066298:In Vitro Techniques; D007627:Keloid / Q000473:pathology / Q000503:physiopathology* / Q000517:prevention & control; D051379:Mice; D023421:Models, Animal; D008954:Models, Biological; D012867:Skin / Q000473:pathology / Q000503:physiopathology; D023822:Tissue Engineering / Q000639:trends*; D014945:Wound Healing / Q000502:physiology
keywords: hypertrophic; in vitro; keloid; organ-on-a-chip; organotypic; scar
references.citation: J Am Coll Surg. 2008 Apr;206(4):731-41
references.pmid: 18387480
references.citation: J Pathol. 2005 May;206(1):1-8
references.pmid: 15772942
references.citation: J Clin Immunol. 1992 Jul;12(4):300-8
references.pmid: 1512303
references.citation: Exp Dermatol. 2012 May;21(5):376-81
references.pmid: 22509836
references.citation: J Pathol. 2007 Jan;211(1):95-108
references.pmid: 17136757
references.citation: J Trauma. 1989 May;29(5):672-7
references.pmid: 2724385
references.citation: Lasers Surg Med. 2005 Sep;37(3):231-44
references.pmid: 16127672
references.citation: Med Hypotheses. 2013 Nov;81(5):807-12
references.pmid: 24074897
references.citation: J Biotechnol. 2010 Jul 1;148(1):38-45
references.pmid: 20416346
references.citation: Br J Plast Surg. 2001 Sep;54(6):511-6
references.pmid: 11513514
references.citation: J Trauma. 2003 Jun;54(6):1212-24
references.pmid: 12813346
references.citation: J Dermatol. 2013 May;40(5):380-3
references.pmid: 23451938
references.citation: Proc Soc Exp Biol Med. 1985 Sep;179(4):549-52
references.pmid: 4022961
references.citation: Plast Reconstr Surg. 1998 Nov;102(6):1962-72
references.pmid: 9810992
references.citation: Nature. 2011 Mar 31;471(7340):661-5
references.pmid: 21455183
references.citation: Exp Dermatol. 2013 Jan;22(1):69-71
references.pmid: 23278899
references.citation: Plast Reconstr Surg. 1999 Oct;104(5):1435-58
references.pmid: 10513931
references.citation: J Leukoc Biol. 2001 Apr;69(4):513-21
references.pmid: 11310836
references.citation: J Invest Dermatol. 2011 Mar;131(3):644-54
references.pmid: 21160497
references.citation: ALTEX. 2012;29(4):389-402
references.pmid: 23138509
references.citation: Wound Repair Regen. 2013 Jul-Aug;21(4):530-44
references.pmid: 23815228
references.citation: Exp Dermatol. 2010 Aug;19(8):e142-50
references.pmid: 20100200
references.citation: Arch Pharm Res. 2012 Feb;35(2):383-8
references.pmid: 22370794
references.citation: Arch Dermatol Res. 2012 Oct;304(8):665-71
references.pmid: 22407077
references.citation: J Invest Dermatol. 2009 Jun;129(6):1569-81
references.pmid: 19122644
references.citation: Wound Repair Regen. 2013 Jan-Feb;21(1):77-87
references.pmid: 23126488
references.citation: Am J Surg. 2008 Feb;195(2):144-8
references.pmid: 18070722
references.citation: Plast Reconstr Surg. 2007 Jan;119(1):104-109
references.pmid: 17255662
references.citation: Cells Tissues Organs. 2005;181(2):89-102
references.pmid: 16534203
references.citation: Endocr Metab Immune Disord Drug Targets. 2010 Dec;10(4):320-30
references.pmid: 20923404
references.citation: Immunobiology. 2011 Jul;216(7):753-62
references.pmid: 21281986
references.citation: Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):153-9
references.pmid: 20881838
references.citation: Mol Med. 2011 Jan-Feb;17(1-2):113-25
references.pmid: 20927486
references.citation: Biomed Res Int. 2013;2013:423147
references.pmid: 24078916
references.citation: J Surg Res. 1999 Dec;87(2):194-200
references.pmid: 10600349
references.citation: Wound Repair Regen. 2007 Jul-Aug;15(4):530-9
references.pmid: 17650097
references.citation: J Pathol. 2005 Oct;207(2):232-42
references.pmid: 16052471
references.citation: Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S6-17
references.pmid: 17727469
references.citation: J Biol Chem. 2003 Oct 17;278(42):40851-8
references.pmid: 12907681
references.citation: Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
references.pmid: 19128254
references.citation: Plast Reconstr Surg. 2006 Jun;117(7 Suppl):12S-34S
references.pmid: 16799372
references.citation: Biomaterials. 2007 Apr;28(13):2183-91
references.pmid: 17280714
references.citation: Stem Cells Dev. 2008 Aug;17(4):713-24
references.pmid: 18710345
references.citation: PLoS One. 2009 Nov 11;4(11):e7798
references.pmid: 19907660
references.citation: J Invest Dermatol. 2009 Apr;129(4):851-61
references.pmid: 19037237
references.citation: Dermatol Surg. 2008 Mar;34(3):336-46
references.pmid: 18177398
references.citation: Cell Mol Immunol. 2004 Apr;1(2):95-104
references.pmid: 16212895
references.citation: Burns. 2009 Feb;35(1):15-29
references.pmid: 18952381
references.citation: J Burn Care Res. 2008 Mar-Apr;29(2):363-8
references.pmid: 18354295
references.citation: Ann Plast Surg. 2010 Sep;65(3):321-5
references.pmid: 20733369
references.citation: Plast Reconstr Surg. 2013 May;131(5):1036-1044
references.pmid: 23629085
references.citation: Laryngoscope. 1987 Oct;97(10):1214-8
references.pmid: 3309514
references.citation: J Cutan Med Surg. 2002 Jul-Aug;6(4):354-9
references.pmid: 12118348
references.citation: J Invest Dermatol. 2009 Feb;129(2):340-7
references.pmid: 18787532
references.citation: Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12
references.pmid: 23401516
references.citation: Am Fam Physician. 2009 Aug 1;80(3):253-60
references.pmid: 19621835
references.citation: J Invest Dermatol. 2003 Dec;121(6):1326-31
references.pmid: 14675177
references.citation: Wound Repair Regen. 2012 May-Jun;20(3):277-83
references.pmid: 22564223
references.citation: Ann Plast Surg. 2005 Jul;55(1):69-75; discussion 75
references.pmid: 15985794
references.citation: J Cell Physiol. 2006 Aug;208(2):336-43
references.pmid: 16705627
references.citation: Science. 2010 Jun 25;328(5986):1662-8
references.pmid: 20576885
references.citation: Br J Dermatol. 2010 Jun;162(6):1377-83
references.pmid: 20192956
references.citation: Science. 2012 Aug 10;337(6095):738-42
references.pmid: 22767894